Company intelligence / Profile preview

inveox

Garching bei München/Munich area, Bayern/Bavaria, Germanyinveox.com ↗

Ownership: Private
Employees: ~55
Development stage: Other

Overview

inveox has developed and commercialized an integrated, automated platform for digitizing and automating the histopathology workflow. Their solution is designed to increase speed, safety, reliability, and efficiency of cancer diagnostics by reducing human error in tissue sample handling. The system is used by laboratories to improve patient outcomes through faster turnaround times and more reliable results

Therapeutic areas: Oncology
Modalities: DeviceDigital platform (automation system for pathology labs)
Industry: Pathology

Partnerships

Participated in Roche Diagnostics/Plug&Play Digital Health Accelerator program

Beyond the preview

Go deeper on inveox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inveox.

Explore the full profile